Oncology nurses’ knowledge, practice, and confidence toward chemotherapy-induced peripheral neuropathy in Jordan

References

1. ↵
   1. Gornstein EL,
   2. Schwarz TL

   (2017) Neurotoxic mechanisms of paclitaxel are local to the distal axon and independent of transport defects. Exp Neurol 288:153–166.

   OpenUrlCrossRefPubMed
2. ↵
   1. Kerckhove N,
   2. Collin A,
   3. Condé S,
   4. Chaleteix C,
   5. Pezet D,
   6. Balayssac D

   (2017) Long-Term Effects, Pathophysiological Mechanisms, and Risk Factors of Chemotherapy-Induced Peripheral Neuropathies:A Comprehensive Literature Review. Front Pharmacol 8:86.

   OpenUrlCrossRefPubMed
3. ↵
   1. Hershman DL,
   2. Lacchetti C,
   3. Loprinzi CL

   (2014) Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers:American Society of Clinical Oncology Clinical Practice Guideline Summary. J Oncol Pract 10:e421–e424.

   OpenUrlFREE Full Text
4. ↵
   1. Tofthagen C,
   2. Visovsky CM,
   3. Hopgood R

   (2013) Chemotherapy-induced peripheral neuropathy:an algorithm to guide nursing management. Clin J Oncol Nurs 17:138–144.

   OpenUrl
5. ↵
   1. Smith EM,
   2. Campbell G,
   3. Tofthagen C,
   4. Kottschade L,
   5. Collins ML,
   6. Warton C,
   7. et al.

   (2014) Nursing knowledge, practice patterns, and learning preferences regarding chemotherapy-induced peripheral neuropathy. Oncol Nurs Forum 41:669–679.

   OpenUrl
6. ↵
   1. Al-Atiyyat N,
   2. Obaid A

   (2017) Management of peripheral neuropathy induced by chemotherapy in adults with cancer:a review. Int J Palliat Nurs 23:13–17.

   OpenUrl
7. ↵
   1. Binner M,
   2. Ross D,
   3. Browner I

   (2011) Chemotherapy-induced peripheral neuropathy:assessment of oncology nurses'knowledge and practice. Oncol Nurs Forum 38:448–454.

   OpenUrlCrossRefPubMed
8. ↵
   1. Schönsteiner SS,
   2. Bauder Mißbach H,
   3. Benner A,
   4. Mack S,
   5. Hamel T,
   6. Orth M,
   7. et al.

   (2017) A randomized exploratory phase 2 study in patients with chemotherapy-related peripheral neuropathy evaluating whole-body vibration training as adjunct to an integrated program including massage, passive mobilization and physical exercises. Exp Hematol Oncol 6:5.

   OpenUrl
9. ↵
   1. Taverner T

   (2014) Neuropathic pain:an overview. British Journal of Neuroscience Nursing 10:116–123.

   OpenUrl
10. ↵
    1. Haryani H,
    2. Fetzer SJ,
    3. Wu CL,
    4. Hsu YY

    (2017) Chemotherapy-Induced Peripheral Neuropathy Assessment Tools:A Systematic Review. Oncol Nurs Forum 44:E111–E123.

    OpenUrl
11. ↵
    1. Visovsky C,
    2. Haas M,
    3. Faiman B,
    4. Kurtin S,
    5. Shaftic AM,
    6. Lyden E,
    7. et al.

    (2012) Nurse self-evaluation of assessment of chemotherapy-induced peripheral neuropathy in patients with cancer. J Adv Pract Oncol 3:319–325.

    OpenUrl
12. ↵
    1. Xue Y,
    2. Schulman-Green D,
    3. Czaplinski C,
    4. Harris D,
    5. McCorkle R

    (2007) Pain attitudes and knowledge among RNs, pharmacists, and physicians on an inpatient oncology service. Clin J Oncol Nurs 11:687–695.

    OpenUrlCrossRefPubMed